Group B Streptococcus and perinatal mortality

Piet Cools; Pierrette Melin

doi:10.1016/j.resmic.2017.04.002

Group B Streptococcus and perinatal mortality

Res Microbiol. 2017 Nov-Dec;168(9-10):793-801. doi: 10.1016/j.resmic.2017.04.002. Epub 2017 Apr 20.

Authors

Piet Cools¹, Pierrette Melin²

Affiliations

¹ Laboratory Bacteriology Research, Department of Microbiology, Immunology and Clinical Chemistry, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium. Electronic address: piet.cools@ugent.be.
² Clinical Microbiology, National Reference Centre for Streptococcus agalactiae, University Hospital of Liège, Faculty of Medicine, Liege University, Liège, Belgium.

PMID: 28435137
DOI: 10.1016/j.resmic.2017.04.002

Abstract

The World Health Organization estimates that every year, one million neonatal deaths occur because of neonatal infection. Furthermore, an equal number of stillbirths are thought to be caused by infections. Here we discuss the role of Streptococcus agalactiae (group B Streptococcus, GBS) in neonatal disease and stillbirth.

Keywords: GBS; Group B Streptococcus; Neonatal disease; Stillbirth; Streptococcus agalactiae.

MeSH terms

Female
Humans
Infant, Newborn
Mucous Membrane / microbiology*
Perinatal Mortality*
Pregnancy
Pregnancy Complications, Infectious / microbiology*
Pregnancy Complications, Infectious / mortality
Pregnancy Complications, Infectious / pathology
Stillbirth
Streptococcal Infections / microbiology*
Streptococcal Infections / pathology
Streptococcus agalactiae / pathogenicity*
Vagina / microbiology*